Pneumonia due to Candida krusei

Clinical Microbiology and Infection

Volumn 8, Issue 12, 2002, Pages 806-809

  Petrocheilou Paschou, V ^a,b   Georgilis, K ^a   Kontoyannis, D ^a   Nanas, J ^a   Prifti, H ^b   Costopoulos, H ^a   Stamatelopoulos, S ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ALEXANDRA HOSPITAL   (Greece)

Author keywords

Candida krusei; Pneumonia; Transplantation

Indexed keywords

AMIKACIN; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; AZATHIOPRINE; CEFEPIME; COTRIMOXAZOLE; CYCLOSPORIN; FLUCONAZOLE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; VANCOMYCIN;

ADULT; ARTICLE; AUTOPSY; CANDIDA ALBICANS; CANDIDA KRUSEI; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CYTOMEGALOVIRUS INFECTION; FEVER; FUNGUS CULTURE; HEART DISEASE; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; LEUKOPENIA; LUNG ALVEOLUS; LUNG INFILTRATE; LUNG LAVAGE; LUNG MYCOSIS; MALE; PLEURISY; PRIORITY JOURNAL; RESPIRATORY FAILURE; THRUSH; TRANSBRONCHIAL BIOPSY;

CANDIDA; CANDIDA ALBICANS; CYTOMEGALOVIRUS; FUNGI; ISSATCHENKIA ORIENTALIS; PNEUMOCYSTIS CARINII;

EID: 0036943337     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2002.00488.x     Document Type: Article

References (14)

1. Viscoli C, Girmenia C, Marinus A et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999; 28: 1071-9.
2. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526-30.
3. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1274-7.
4. Abi-Said d Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24: 1122-8.
5. White MH. Editorial response: The contribution of fluconazole to the changing epidemiology of invasive candidal infections. Clin Infect Dis. 1997; 24: 1129-30.
6. Singh N. Changing spectrum of invasive candidiasis and its therapeutic implications. Clin Microbiol Infect 2001; 7(Suppl. 2): S1-7.
7. Hibberd PL, Rubin RH. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis 1995; 19(Suppl. 1): S33-40.
8. Petri WA Jr. Infections in heart transplant recipients. Clin Infect Dis 1994; 18: 141-6.
9. Hofflin JM, Potasman I, Baldwin JC, Oyer PE, Stinson EB, Remington JS. Infectious complications in heart transplant recipients receiving cyclosporin and corticosteroids. Ann Intern Med 1987; 106: 209-16.
10. Nguyen VQ, Penn RL. Candida krusei infectious arthritis. A rare complication of neutropenia. Am J Med 1987; 83: 963-5.
11. McQuillen DP, Zingman BS, Meunier F, Levitz SM. Invasive infections due to Candida krusei: report of ten cases of fungemia that include three cases of endophthalmitis. Clin Infect Dis 1992; 14: 472-8.
12. Gordon RA, Simmons BP, Appelbaum PC, Aber RC. Intra-abdominal abscess and fungemia caused by Candida krusei. Arch Intern Med 1980; 140: 1239-40.
13. Cisneros JM, Munoz P, Torre-Cisneros J et al. Pneumonia after heart transplantation: a multi-institutional study. Clin Infect Dis 1998; 27: 324-31.
14. Fishman JA, Rubin RH. Infection in organ-transplantation recipients. N Engl J Med 1998; 338: 1741-51.